Cooper Companies COO

$62.65 +0.46 (0.74%)

Valuation

Market cap
11,825,739,000
Revenue TTM
$4,092,400,000
Net income TTM
$374,900,000
P/E (trailing)
13.65
P/E (forward)
13.41
Profit margin
9.16%
Debt to equity
0.31

Trading

Volume
1,574,200
Avg volume
4,071,150
Day's range
$62.14 – $63.03
Shares out
190,155,000
Stochastic %K
46%
Beta
0.83
Analysts
Hold
Price target
$65.44

Price

Company profile

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, whic...

Show more

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
925 460 3600
Website
https://www.coopercos.com
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, United States

Latest news

Stocktwits

WallStJesus Nov 13, 5:09 PM
$FISV $COO -
0 replies
PetersMeter Nov 13, 9:35 AM
$COO The next few steps could be more important than people realize
0 replies
RealEmkay Nov 9, 6:42 PM
$COO back to 75+ before earnings
0 replies
Ruey Nov 7, 3:10 PM
$COO I'd like to see this earn its reputation one result at a time.
0 replies
GTA_Terminal Nov 7, 10:47 AM
Dark pool check on $COO: what traded off the exchanges this session. The stock moved -1.8% on the day, so this wasn't happening in a quiet tape. Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days: https://globaltradersacademy.com/start-trial?a=stocktwits&sym=COO&utm_source=stocktwits&utm_medium=social&utm_campaign=trial&utm_content=COO Read the full article for the full details: https://globaltradersacademy.com/articles/dark-pool-check-cooper-companies-coo?utm_source=stocktwits&utm_medium=social
0 replies
kbingo12 Oct 28, 12:57 PM
$COO interesting timing for COO firing CEO... Brents's term agreement w/BLCO does not detail the specific restrictive covenants or non-compete clauses included in his separation agreement regarding individual competitors like Cooper or Alcon.
0 replies
filecrux Oct 28, 1:56 AM
$COO Will CooperCompanies' CEO exit, 7 weeks after its board chose to keep CooperSurgical, put a sale back on the table? 👤 CooperCompanies, the contact lens and fertility device maker worth about $11.39B at $59.89 a share at 16:00 ET on October 27, 2026, said CEO Albert White III left effective immediately, with director Walt Rosebrough running operations as interim Executive Chair 💰 Today the company reaffirmed fiscal 2026 non-GAAP EPS guidance of $4.51-$4.55, which puts the stock at about 13 times earnings and below the $69.16 average it paid for shares in fiscal Q3 🏢 On Sept 9 the board said temporary factors, a rival non-hormonal IUD and a fertility litigation settlement, depressed CooperSurgical offers, but that it will 'always remain open to value creating alternatives' 📅 Next: Shlomo Nachman, ex-J&J vision chief, joins the board December 8, 2026; an 8-K amendment will set out White's extra pay Source: SEC 8-K, Oct 27 + SEC 8-K, Sept 9
0 replies
TalkMarkets Oct 10, 1:54 AM
Cooper Cooper Cooper $COO https://talkmarkets.com/article/cooper-cooper-cooper
0 replies